- Home
- HIX vs AUTL Comparison
HIX vs AUTL Comparison
Compare HIX & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.67
Company Overview
Basic Information| Metric | HIX | AUTL |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.6M | 433.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HIX | AUTL |
|---|---|---|
| Price | $4.11 | $1.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | 449.5K | ★ 2.4M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 13.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $51,128,000.00 |
| Revenue This Year | N/A | $669.49 |
| Revenue Next Year | N/A | $91.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $4.16 | $1.11 |
| 52 Week High | $5.08 | $2.80 |
Technical Indicators
Market Signals| Indicator | HIX | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 57.88 |
| Support Level | $4.06 | $1.63 |
| Resistance Level | $4.19 | $1.79 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 46.15 | 59.09 |
Price Performance
Historical Comparison HIX
AUTL
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.